Notes / Company

Asston Pharmaceuticals Ltd.

APL BSE 544445 ISIN INE0SJX01015 Pharmaceuticals

Fundamentals

Market cap: ₹68.95 cr
P/E: 17.84×
ROE: 40.35%
Debt / equity: 0.68
52-week range: 61.02 — 126.00

Research on Tijori Finance

Company snapshot

Asston Pharmaceuticals Ltd.

Pharmaceuticals

₹63 cr

P/E 16.30×

Latest quarter · Mar 2026

Sales₹10 cr

Net profit₹0 cr

Op. margin−27.8%

EPS₹0.57

Strength & growth

Debt / equity0.68×

Current ratio1.80×

The timeline — 1 note on Asston Pharmaceuticals Ltd.

July 2026

02 Jul 26 · 6:26 PM IST Lead

Lead · Micro cap

Asston Pharma to raise ₹27.7 cr via preferential issue, 28% dilution

The nano-cap pharma company is selling a 28% stake to non-promoter investors, including a 12% block to Vijay Rathee, in a deal that could reshape control and pricing.

Verify on exchange BSE filings for APL NSE filings for APL Tijori Finance company page